Back to today’s briefing

Story perspectives

Study Confirms Safety of Molybdenum in Medical Implants

7/29/2025

29 6

Summary

Story summary

A groundbreaking study from Xuanwu Hospital and Peking University reveals that elevated levels of molybdenum (Mo) in biomedical implants pose no genetic risk for cardiovascular or cerebrovascular disorders. Published in *Genes & Diseases*, this research bolsters the safety of Mo-based biomaterials, opening doors for their expanded use in medical devices and enhancing patient care.

1 of 1

Story summary

A groundbreaking study from Xuanwu Hospital and Peking University reveals that elevated levels of molybdenum (Mo) in biomedical implants pose no genetic risk for cardiovascular or cerebrovascular disorders. Published in *Genes & Diseases*, this research bolsters the safety of Mo-based biomaterials, opening doors for their expanded use in medical devices and enhancing patient care.